Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PC:INSIL
Private Companies
Insilico Medicine Highlights Intern Contributions to AI-Driven Drug Discovery R&D
2h ago
INSIL
Premium
Private Companies
Insilico Medicine Showcases Phase 2a IPF Data for AI-Designed Drug Rentosertib at PVRI 2026
2h ago
INSIL
Premium
Private Companies
Insilico Medicine Advances AI-Discovered Obesity Candidate ISM0676 to Preclinical Milestone
20h ago
INSIL
Premium
Private Companies
Insilico Medicine Showcases AI ‘MMAI Gym’ Platform for Drug Discovery Following GEN Coverage
20h ago
INSIL
Premium
Private Companies
Insilico Medicine Highlights AI Gym Launch and FDA Clearance for AI-Designed NLRP3 Inhibitor
20h ago
INSIL
Premium
Private Companies
Insilico Medicine Advances AI-Designed Obesity Drug ISM0676 and Deepens Cardiometabolic Focus
1d ago
INSIL
Premium
Private Companies
Insilico Medicine Expands Longevity AI Research Team with Senior Hire in Abu Dhabi
3d ago
INSIL
Premium
Private Companies
Insilico Medicine Signs $120 Million AI-Driven Cardiometabolic Drug Pact With Qilu Pharma
3d ago
INSIL
Premium
Private Companies
Insilico Medicine Showcases MMAI Gym Platform for AI-Driven Drug Development
4d ago
INSIL
Premium
Private Companies
Insilico Medicine – Weekly Recap
6d ago
INSIL
Premium
Private Companies
Insilico Medicine Wins FDA IND Clearance and Signs Global Co-Development Deal for AI-Designed NLRP3 Inhibitor ISM8969
7d ago
INSIL
Premium
Private Companies
Insilico Medicine Opens ‘Science MMAI Gym’ to Turn General LLMs into Drug Discovery Engines
8d ago
INSIL
Premium
Private Companies
Insilico Medicine Raises HKD 2.3 Billion in Record Hong Kong Biotech IPO to Scale AI-Driven Drug R&D
9d ago
INSIL
Premium
Private Companies
Insilico Medicine Secures Up To US$888 Million Servier Oncology Partnership After Hong Kong Listing
9d ago
INSIL
Premium
Private Companies
Insilico Advances AI-Designed IBD Drug Into Phase IIa as HK-Listed Platform Shows Pipeline Momentum
9d ago
INSIL
Premium
Private Companies
Insilico Medicine Strikes 50-50 Global Co-Development Deal on AI-Discovered NLRP3 Inhibitor ISM8969
9d ago
INSIL
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
